Patient experiences with dipeptidylpeptidase-4 inhibitors: Analysis of online discussion forums

被引：0
|
作者：
Bellet, F. [1 ]
Mounier, G. [1 ]
Marsille, F. [1 ]
Guy, C. [1 ]
Beyens, M. N. [1 ]
机构：
[1] CHU St Etienne, Ctr Pharmacovigilance, St Etienne, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2015年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PM1-022
引用
收藏
页码：24 / 25
页数：2
相关论文
共 50 条
  • [1] Pharmacokinetics of dipeptidylpeptidase-4 inhibitors
    Scheen, A. J.
    [J]. DIABETES OBESITY & METABOLISM, 2010, 12 (08): : 648 - 658
  • [2] Pleiotropic effects of the dipeptidylpeptidase-4 inhibitors on the cardiovascular system
    Aroor, Annayya R.
    Sowers, James R.
    Jia, Guanghong
    DeMarco, Vincent G.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2014, 307 (04): : H477 - H492
  • [3] Do Persistence Rates Vary between Dipeptidylpeptidase-4 Inhibitors?
    Mcgovern, Andrew P.
    Hinton, William
    Munro, Neil M.
    Whyte, Martin B.
    De Lusignan, Simon
    [J]. DIABETES, 2016, 65 : A576 - A576
  • [4] Dipeptidylpeptidase-4 inhibitors in the treatment of diabetes mellitus. Possibilities of cardioprotection
    Trunina, E. N.
    Petunina, N. A.
    Chorbinskaya, S. A.
    [J]. DIABETES MELLITUS, 2011, 14 (02): : 59 - 64
  • [5] Dipeptidylpeptidase-4 Inhibitors (Gliptins)Focus on Drug-Drug Interactions
    André J. Scheen
    [J]. Clinical Pharmacokinetics, 2010, 49 : 573 - 588
  • [6] Patient Perspectives of Dabigatran: Analysis of Online Discussion Forums
    Sarrazin, Mary S. Vaughan
    Cram, Peter
    Mazur, Alexandur
    Ward, Melissa
    Reisinger, Heather Schacht
    [J]. PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2014, 7 (01): : 47 - 54
  • [7] Patient Perspectives of Dabigatran: Analysis of Online Discussion Forums
    Mary S. Vaughan Sarrazin
    Peter Cram
    Alexandur Mazur
    Melissa Ward
    Heather Schacht Reisinger
    [J]. The Patient - Patient-Centered Outcomes Research, 2014, 7 : 47 - 54
  • [8] The role of dipeptidylpeptidase-4 inhibitors in management of cardiovascular disease in diabetes; focus on linagliptin
    Aroor, Annayya R.
    Manrique-Acevedo, Camila
    DeMarco, Vincent G.
    [J]. CARDIOVASCULAR DIABETOLOGY, 2018, 17
  • [9] The role of dipeptidylpeptidase-4 inhibitors in management of cardiovascular disease in diabetes; focus on linagliptin
    Annayya R. Aroor
    Camila Manrique-Acevedo
    Vincent G. DeMarco
    [J]. Cardiovascular Diabetology, 17
  • [10] Erratum to: Dipeptidylpeptidase-4 inhibitors (gliptins): focus on drug-drug interactions
    AJ Scheen
    [J]. Clinical Pharmacokinetics, 2011, 50 (1) : 74 - 74
12345